REMTOLUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

REMTOLUMAB

Official Name

English

remtolumab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A) AND HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)), HOMO SAPIENS MONOCLONAL ANTIBODY, TETRAVALENT BISPECIFIC GAMMA1 HEAVY CHAIN (1-

Systematic Name

English

Remtolumab [WHO-DD]

Common Name

English

ABT-122

Code

English

IMMUNOGLOBULIN, ANTI-(TUMOR NECROSIS FACTOR .ALPHA./INTERLEUKIN 17) (SYNTHETIC HUMAN A-1230717 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN A-1230717 LIGHT CHAIN, DIMER

Systematic Name

English

A-1230717

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

NCI_THESAURUS

C1454

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

Code System Code Type Description

INN

10345

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

PRIMARY

NCI_THESAURUS

C152189

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

PRIMARY

CAS

1791410-27-9

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

PRIMARY

DRUG BANK

DB15128

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

PRIMARY

IUPHAR

9597

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

PRIMARY

FDA UNII

1V8WRH3RVX

Created by admin on Sat Dec 16 11:37:12 GMT 2023 , Edited by admin on Sat Dec 16 11:37:12 GMT 2023

PRIMARY

ACTIVE MOIETY


					1V8WRH3RVX